Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amyloid beta: the alternate hypothesis.

Hyoung-gon Lee1, Xiongwei Zhu, Akihiko Nunomura

  • 1Institute of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.

Current Alzheimer Research
|February 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repetitive transcranial magnetic stimulation for residual depressive symptoms after electroconvulsive therapy in an elderly patient with treatment-resistant depression.

PCN reports : psychiatry and clinical neurosciences·2024
Same author

Is dementia praecox still the "graveyard of neuropathologists"?

Psychiatry and clinical neurosciences·2024
Same author

A Qualitative Study on the Recovery Process and Its Associated Factors in Morita Therapy for Inpatients with Mood Disorders.

Journal of clinical medicine·2023
Same author

A case of treatment-resistant depression with psychogenic movement disorder during repetitive transcranial magnetic stimulation.

Asian journal of psychiatry·2021
Same author

A case presenting with persecutory delusions as an initial symptom of elderly bipolar disorder.

Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society·2021
Same author

Repetitive transcranial magnetic stimulation for treatment-resistant depression in an elderly patient with an unruptured intracranial aneurysm: a case report.

Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society·2021
Same journal

The Role of Digital Health Technologies in Early Detection and Management of Alzheimer's Disease.

Current Alzheimer research·2026
Same journal

Quantifying Short-Term Functional Changes After Lecanemab Treatment in Early Alzheimer's Disease: An Exploratory 3-Month Follow-Up Case Report Using Eye Movement and Gait Analysis.

Current Alzheimer research·2026
Same journal

Corrigendum to: Advancing Alzheimer's Disease Diagnosis Using VGG19 and XGBoost: A Neuroimaging-Based Method.

Current Alzheimer research·2026
Same journal

Corrigendum to: Lithium Chloride Improves Electrophysiological and Memory Deficits in Rats with Streptozotocin-Induced Alzheimer's Disease.

Current Alzheimer research·2026
Same journal

Apolipoprotein E Mimetics in Targeted Drug Delivery: Advances and Therapeutic Potential for Neurodegenerative and Cardiovascular Diseases.

Current Alzheimer research·2026
Same journal

Association of Polymorphisms in Genes Involved in Serotonergic Signaling with the Risk of Developing Alzheimer's Disease.

Current Alzheimer research·2026
See all related articles

Oxidative stress, not amyloid-beta, may initiate Alzheimer disease (AD). This alternate hypothesis suggests amyloid-beta may protectively reduce oxidative stress, offering new therapeutic targets for AD.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Alzheimer disease (AD) research predominantly follows the Amyloid Cascade Hypothesis, focusing on amyloid-beta (Abeta) as the primary cause.
  • Genetic mutations in AD are linked to increased oxidative stress and redox imbalance, questioning the sole focus on Abeta.
  • The causal relationship between Abeta deposition and oxidative stress in AD remains debated, with evidence supporting both directions.

Discussion:

  • In vivo studies indicate oxidative stress precedes Abeta increases in both sporadic and genetic AD.
  • Abeta accumulation correlates with decreased oxidative stress, suggesting a protective role.
  • The Alternate Amyloid Hypothesis proposes that oxidative stress initiates AD pathogenesis, leading to Abeta formation.

Key Insights:

Related Experiment Videos

  • Pathogenic factors in AD may first increase oxidative stress, which then drives Abeta production.
  • Amyloid-beta may function as a redox sensor, acting to mitigate oxidative damage.
  • Re-evaluating Abeta's role from culprit to potential protector is crucial for understanding AD.

Outlook:

  • Deciphering the precise role of Abeta in AD pathogenesis is critical for developing effective therapeutics.
  • The Alternate Amyloid Hypothesis offers a new framework for AD research and drug development.
  • Targeting oxidative stress pathways could represent a novel therapeutic strategy for Alzheimer disease.